Logo image of WOOF

PETCO HEALTH AND WELLNESS CO (WOOF) Stock Fundamental Analysis

NASDAQ:WOOF - Nasdaq - US71601V1052 - Common Stock - Currency: USD

2.95  -0.07 (-2.32%)

Premarket: 2.98 +0.03 (+1.02%)

Fundamental Rating

2

Overall WOOF gets a fundamental rating of 2 out of 10. We evaluated WOOF against 121 industry peers in the Specialty Retail industry. Both the profitability and financial health of WOOF have multiple concerns. WOOF is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

WOOF had negative earnings in the past year.
In the past year WOOF had a positive cash flow from operations.
In multiple years WOOF reported negative net income over the last 5 years.
Each year in the past 5 years WOOF had a positive operating cash flow.
WOOF Yearly Net Income VS EBIT VS OCF VS FCFWOOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

1.2 Ratios

WOOF has a Return On Assets of -1.96%. This is in the lower half of the industry: WOOF underperforms 62.81% of its industry peers.
The Return On Equity of WOOF (-9.14%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.14%, WOOF is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for WOOF is significantly below the industry average of 13.08%.
Industry RankSector Rank
ROA -1.96%
ROE -9.14%
ROIC 0.14%
ROA(3y)-8.15%
ROA(5y)-4.47%
ROE(3y)-37.81%
ROE(5y)-21.49%
ROIC(3y)1.45%
ROIC(5y)2.27%
WOOF Yearly ROA, ROE, ROICWOOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Operating Margin, with a value of 0.12%, WOOF is doing worse than 63.64% of the companies in the same industry.
WOOF's Operating Margin has declined in the last couple of years.
The Gross Margin of WOOF (38.00%) is comparable to the rest of the industry.
WOOF's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.12%
PM (TTM) N/A
GM 38%
OM growth 3Y-62.42%
OM growth 5Y-38.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-2.44%
WOOF Yearly Profit, Operating, Gross MarginsWOOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WOOF is destroying value.
WOOF has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WOOF has more shares outstanding
The debt/assets ratio for WOOF is higher compared to a year ago.
WOOF Yearly Shares OutstandingWOOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
WOOF Yearly Total Debt VS Total AssetsWOOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

WOOF has an Altman-Z score of 0.97. This is a bad value and indicates that WOOF is not financially healthy and even has some risk of bankruptcy.
WOOF's Altman-Z score of 0.97 is on the low side compared to the rest of the industry. WOOF is outperformed by 74.38% of its industry peers.
WOOF has a debt to FCF ratio of 31.87. This is a negative value and a sign of low solvency as WOOF would need 31.87 years to pay back of all of its debts.
WOOF has a Debt to FCF ratio (31.87) which is in line with its industry peers.
A Debt/Equity ratio of 1.42 is on the high side and indicates that WOOF has dependencies on debt financing.
WOOF has a worse Debt to Equity ratio (1.42) than 62.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF 31.87
Altman-Z 0.97
ROIC/WACC0.01
WACC10.14%
WOOF Yearly LT Debt VS Equity VS FCFWOOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.85 indicates that WOOF may have some problems paying its short term obligations.
WOOF has a worse Current ratio (0.85) than 84.30% of its industry peers.
WOOF has a Quick Ratio of 0.85. This is a bad value and indicates that WOOF is not financially healthy enough and could expect problems in meeting its short term obligations.
WOOF's Quick ratio of 0.28 is on the low side compared to the rest of the industry. WOOF is outperformed by 78.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.28
WOOF Yearly Current Assets VS Current LiabilitesWOOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

WOOF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -168.89%.
The Revenue has decreased by -2.22% in the past year.
Measured over the past years, WOOF shows a small growth in Revenue. The Revenue has been growing by 6.64% on average per year.
EPS 1Y (TTM)-168.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)-2.22%
Revenue growth 3Y1.75%
Revenue growth 5Y6.64%
Sales Q2Q%-7.31%

3.2 Future

The Earnings Per Share is expected to grow by 55.44% on average over the next years. This is a very strong growth
Based on estimates for the next years, WOOF will show a small growth in Revenue. The Revenue will grow by 0.31% on average per year.
EPS Next Y270.5%
EPS Next 2Y130.13%
EPS Next 3Y98.82%
EPS Next 5Y55.44%
Revenue Next Year-1.87%
Revenue Next 2Y-0.13%
Revenue Next 3Y0.73%
Revenue Next 5Y0.31%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WOOF Yearly Revenue VS EstimatesWOOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
WOOF Yearly EPS VS EstimatesWOOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

WOOF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 27.91 indicates a quite expensive valuation of WOOF.
WOOF's Price/Forward Earnings ratio is in line with the industry average.
WOOF's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.20.
Industry RankSector Rank
PE N/A
Fwd PE 27.91
WOOF Price Earnings VS Forward Price EarningsWOOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

WOOF's Enterprise Value to EBITDA ratio is in line with the industry average.
66.12% of the companies in the same industry are more expensive than WOOF, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.71
EV/EBITDA 11.35
WOOF Per share dataWOOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WOOF's earnings are expected to grow with 98.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y130.13%
EPS Next 3Y98.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WOOF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PETCO HEALTH AND WELLNESS CO

NASDAQ:WOOF (4/30/2025, 8:00:02 PM)

Premarket: 2.98 +0.03 (+1.02%)

2.95

-0.07 (-2.32%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)05-20 2025-05-20/bmo
Inst Owners69.08%
Inst Owner Change0.02%
Ins Owners4.23%
Ins Owner Change30.72%
Market Cap929.63M
Analysts71.11
Price Target3.84 (30.17%)
Short Float %39.61%
Short Ratio6.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)82.85%
Min EPS beat(2)47.57%
Max EPS beat(2)118.13%
EPS beat(4)4
Avg EPS beat(4)55.54%
Min EPS beat(4)15.3%
Max EPS beat(4)118.13%
EPS beat(8)7
Avg EPS beat(8)-8.77%
EPS beat(12)9
Avg EPS beat(12)-6.85%
EPS beat(16)13
Avg EPS beat(16)2.4%
Revenue beat(2)0
Avg Revenue beat(2)-1.89%
Min Revenue beat(2)-2.5%
Max Revenue beat(2)-1.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)-0.9%
Revenue beat(8)2
Avg Revenue beat(8)-1.1%
Revenue beat(12)2
Avg Revenue beat(12)-1.33%
Revenue beat(16)5
Avg Revenue beat(16)-0.08%
PT rev (1m)-22.72%
PT rev (3m)-22.72%
EPS NQ rev (1m)-0.76%
EPS NQ rev (3m)-47.57%
EPS NY rev (1m)124.43%
EPS NY rev (3m)80.78%
Revenue NQ rev (1m)-3.9%
Revenue NQ rev (3m)-4.26%
Revenue NY rev (1m)-4.42%
Revenue NY rev (3m)-4.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.91
P/S 0.15
P/FCF 18.71
P/OCF 5.23
P/B 0.83
P/tB N/A
EV/EBITDA 11.35
EPS(TTM)-0.06
EYN/A
EPS(NY)0.11
Fwd EY3.58%
FCF(TTM)0.16
FCFY5.34%
OCF(TTM)0.56
OCFY19.11%
SpS19.41
BVpS3.53
TBVpS-2.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.96%
ROE -9.14%
ROCE 0.17%
ROIC 0.14%
ROICexc 0.14%
ROICexgc 0.3%
OM 0.12%
PM (TTM) N/A
GM 38%
FCFM 0.81%
ROA(3y)-8.15%
ROA(5y)-4.47%
ROE(3y)-37.81%
ROE(5y)-21.49%
ROIC(3y)1.45%
ROIC(5y)2.27%
ROICexc(3y)1.5%
ROICexc(5y)2.35%
ROICexgc(3y)3.54%
ROICexgc(5y)5.94%
ROCE(3y)1.84%
ROCE(5y)2.88%
ROICexcg growth 3Y-60.84%
ROICexcg growth 5Y-33.82%
ROICexc growth 3Y-57.79%
ROICexc growth 5Y-30.5%
OM growth 3Y-62.42%
OM growth 5Y-38.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-2.44%
F-Score5
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF 31.87
Debt/EBITDA 7.63
Cap/Depr 64.08%
Cap/Sales 2.09%
Interest Coverage 0.05
Cash Conversion 85.92%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.28
Altman-Z 0.97
F-Score5
WACC10.14%
ROIC/WACC0.01
Cap/Depr(3y)106.63%
Cap/Depr(5y)109.98%
Cap/Sales(3y)3.43%
Cap/Sales(5y)3.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-168.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y270.5%
EPS Next 2Y130.13%
EPS Next 3Y98.82%
EPS Next 5Y55.44%
Revenue 1Y (TTM)-2.22%
Revenue growth 3Y1.75%
Revenue growth 5Y6.64%
Sales Q2Q%-7.31%
Revenue Next Year-1.87%
Revenue Next 2Y-0.13%
Revenue Next 3Y0.73%
Revenue Next 5Y0.31%
EBIT growth 1Y-83.27%
EBIT growth 3Y-61.76%
EBIT growth 5Y-34.33%
EBIT Next Year254.81%
EBIT Next 3Y61.09%
EBIT Next 5Y33.97%
FCF growth 1Y602.92%
FCF growth 3Y-25.28%
FCF growth 5YN/A
OCF growth 1Y-17.64%
OCF growth 3Y-20.84%
OCF growth 5Y10%